Adrien Bouglé on Comparison Between Regional Citrate Anticoagulation and Systemic Heparin
Adrien Bouglé, Head of Cardiac ICU and Anesthesiology, Full Professor, Sorbonne University, La Pitié – Salpêtrière, shared on LinkedIn:
”Very pleased to share our latest multicentric study comparing regional citrate anticoagulation and systemic heparin in patients undergoing VA-ECMO and continuous renal replacement therapy.
RCA was associated with a significantly lower risk of CRRT filter thrombosis, without increasing bleeding or severe metabolic complications — supporting its use in this high-risk population.”
Read the full article here.
Article: Comparison between regional citrate anticoagulation and systemic heparin anticoagulation in patients undergoing continuous renal replacement therapy and venoarterial extracorporeal membrane oxygenation: A retrospective multicentric study
Authors: Axel Hirwe, Edris Omar, Pierre-Grégoire Guinot, Antoine Beurton, Nicolas Nesseler, Alexandre Mansour, Vivien Berthoud, Alexandre Ouattara, Stéphanie Rouanet, Guillaume Lebreton, Geoffroy Hariri, Adrien Bouglé
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 14:14New Insights Into Platelet Production in Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: Takeaways from the 3rd Global Sickle Cell Disease Conference Nairobi
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week